Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In a phase 2 trial involving people with obesity, the 12 mg weekly dose of retatrutide resulted in a placebo-adjusted mean weight reduction of 22.1% after 48 weeks of treatment
GLP-1
Among the 37 patients initially put on naltrexone-bupropion, 11 of them (29.7%) continued naltrexone-bupropion up to 18 months, 9 of them (24.3%) continued up to 24 months and 8 of them (21.6%) continued up to 30 months
45 Serum levels of RANKL, OPG, and their ratio were assessed in postmenopausal women who were treated with genistein for 24 months
US$ 27.46
US$ 28.23
US$ 22.04
